silane as an internal standard, integration, multiplicity (s=singlet,
d=doublet, t=triplet, q=quartet, dd=double-doublet, m=mul-
tiplet, br=broad), coupling constants (in Hz), and assignment.
13C NMR spectra were measured at 75, 100, 125, or 150 MHz with
complete proton decoupling. Chemical shifts are reported in ppm
from the residual solvent as an internal standard. Reactions were
monitored by TLC on silica [alu-plates (0.2 mm)]. Plates were visual-
ized with UV light (l 254 nm) and by treatment with ethanolic p-
anisaldehyde with sulfuric and glacial acetic acid followed by heat-
ing, aqueous cerium(IV) sulfate solution with molybdic and sulfuric
acid followed by heating, or ethanolic ninhydrin solution followed
by heating. All organic solutions were dried over anhydrous
sodium sulfate. Reaction products were purified by flash chroma-
tography using silica gel 60 (240–400 mesh). HPLC analyses were
performed on an HPLC system equipped with chiral stationary
phase columns, detection at l 254 nm.
argon. A mixture of protected heptitols 8 (45 mg, 0.13 mmol) was
dissolved in anhydrous DMF, and imidazole (10 mol%) was added.
The reaction mixture was cooled to 08C, and NaH (60% dispersion
in mineral oil, 41.3 equiv) was added. After 30 min BnBr (4
1.2 equiv) and Bu4NI (40.12 equiv) were added, and the reaction
was monitored by TLC. After 2 h H2O was added to the reaction
mixture and the aqueous phase was washed with EtOAc. The or-
ganic phase was washed with brine, dried, concentrated, purified
by flash column chromatography (hexane/EtOAc 9:1) and submit-
ted to the next step. After the substrate was dissolved in MeOH,
Amberlyst 15 hydrogen form was added, and the vial with the mix-
ture was placed on a laboratory shaker. After 24 h the reaction mix-
ture was filtered, concentrated, purified by flash column chroma-
tography (hexane/EtOAc 3:1), and submitted to the next step. Re-
moval of benzyl groups was performed by hydrogenation in the
presence of palladium on charcoal. The substrate was dissolved in
MeOH, and Pd/C was added. After 20 h of stirring under hydrogen
atmosphere the reaction mixture was filtered through a Celite plug
d-Erythrose (3),[14] d-xylose (5),[16] and d-arabinose (11)[17] aceto-
nides were prepared according to published procedures. Synthesis
and spectroscopic data for organocatalysts 6 and ent-6 were
described previously.[18]
1
and concentrated. Yield 16 mg, 63%; H NMR (400 MHz, D2O): d=
3.91–3.86 (m, 2H), 3.86–3.83 (m, 1H), 3.83–3.80 (m, 1H), 3.80–3.77
(m, 2H), 3.77–3.75 (m, 2H), 3.75–3.73 (m, 2H), 3.72–3.68 (m, 2H),
3.68–3.65 (m, 1H), 3.65–3.61 (m, 2H), 3.61–3.54 (m, 1H); 13C NMR
(100 MHz, D2O): d=74.3, 74.2, 73.9, 73.0, 72.8, 72.1, 71.2, 71.0, 70.9,
64.5, 63.8, 63.5, 63.4; IR (ATR, ZnSe): 3364, 2938, 1648, 1598, 1418,
General procedure for the aldol reaction of dihydroxyacetone
(Schemes 3–5): To a solution of aldehyde (0.5 mmol) in DMF/H2O
(9:1, 0.5 mL), 1,3-dihydroxyacetone dimer 4 (180 mg, 1 mmol;
2 mmol as a monomer) was added. After the substrates dissolved,
organocatalyst 6 or ent-6 (20 mol%) was added to the reaction
mixture. The reaction was stirred at room temperature and moni-
tored by TLC. The reaction mixture was poured directly on silica
gel. The aldol product was purified by flash column chromatogra-
phy (CHCl3/MeOH, 97:3).
1311 cmÀ1
; HRMS (ESI) exact mass calcd for C7H16O7Na m/z
235.0794 [M+Na]+, found m/z 235.0796 [M+Na]+.
1H and 13C NMR spectra of the mixture of peracetylated heptitols
9a/9b also match previously published data.[15] The peracetylation
reaction was performed under argon. The mixture of heptitols 9a
and 9b (12 mg, 0.05 mmol) was dissolved in dry pyridine, Ac2O
(30 equiv) and DMAP (10 mol%) were added, and the reaction was
kept at room temperature for 24 h. MeOH was added, and the mix-
ture was concentrated under reduced pressure. The residue was
partitioned between CH2Cl2 and 5% aqueous HCl. The organic
layer was washed with 5% aqueous NaHCO3, dried, concentrated,
and purified by flash column chromatography (hexane/EtOAc, 3:2).
d-Altro-hept-2-ulose (7, Scheme 3): Yield 132 mg, 78%; [a]22
=
D
1
À12.9 (c=2.38, CHCl3); H NMR (400 MHz, CDCl3): d=7.38–7.27 (m,
5H), 4.57 (d, J=5.3 Hz, 2H), 4.55–4.50 (m, 1H), 4.48–4.37 (m, 3H),
4.34 (dd, J=9.2, 5.7 Hz, 1H), 4.06 (ddd, J=9.2, 3.5, 1.5 Hz, 1H), 3.93
(d, J=3.9 Hz, 1H), 3.72 (t, J=9.5 Hz, 1H), 3.58 (dd, J=9.8, 3.9 Hz,
1H), 3.19 (d, J=8.3 Hz, 1H), 3.01 (brs, 1H), 1.39 (s, 3H), 1.35 (s,
3H); 13C NMR (100 MHz, CDCl3): d=211.7, 136.4, 128.9, 128.7, 128.3,
109.2, 76.2, 75.8, 75.1, 74.4, 70.0, 68.3, 67.1, 28.0, 25.4; IR (film,
CHCl3): 3412, 2986, 2932, 2872, 1726, 1455, 1382, 1375 cmÀ1; HRMS
(ESI) exact mass calcd for C17H24O7Na m/z 363.1420 [M+Na]+,
found m/z 363.1429 [M+Na]+.
1
Yield 20 mg, 79%; H NMR (400 MHz, CDCl3): d=5.47–5.40 (m, 1H),
5.40–5.36 (m, 1H), 5.27–5.18 (m, 1H), 5.16–5.10 (m, 1H), 5.09–5.02
(m, 1H), 4.38–4.28 (m, 1H), 4.25–4.15 (m, 2H), 4.04 (dd, J=12.5,
5.3 Hz, 0.71H), 3.96 (dd, J=11.7, 6.3 Hz, 0.31H), 2.15 (s, 0.9H),
2.14 (s, 0.9H), 2.13 (s, 2.1H), 2.10 (s, 0.9H), 2.07 (s, 0.9H), 2.06 (s,
2.1H), 2.06 (s, 4H), 2.04 (s, 5H), 2.04 (s, 2.1H), 2.03 (s, 0.9H), 2.02 (s,
0.9H); 13C NMR (100 MHz, CDCl3): d=170.8, 170.7, 170.7, 170.4,
170.4, 170.1, 170.1, 170.1, 170.0, 169.9, 169.9, 169.7, 169.7, 169.4,
70.3, 70.1, 69.4, 69.2, 68.8, 68.7, 68.5, 68.2, 67.9, 67.6, 61.9, 61.7,
61.6, 61.5, 21.0, 21.0, 20.9, 20.9, 20.9, 20.8, 20.8, 20.8, 20.8, 20.7,
20.7, 20.6; IR (film, CHCl3): 1749, 1434, 1372, 1217 cmÀ1; HRMS (ESI)
exact mass calcd for C21H30O14Na m/z 529.1533 [M+Na]+, found
m/z 529.1536 [M+Na]+.
7-O-Benzyl-5,6-O-isopropylidene-d-glycero-d-mannoheptitol and
7-O-benzyl-5,6-O-isopropylidene-d-glycero-d-glucoheptitol
(8,
Scheme 3): After the aldol product 7 was dissolved in CH2Cl2/
MeOH (9:1) and cooled to 08C, NaBH4 (1.2 equiv) was added, and
the reaction mixture was stirred for 2 h. Next the mixture was dilut-
ed with CH2Cl2 and washed with saturated solution of sodium hy-
drogen carbonate. The aqueous phase was extracted with CH2Cl2,
and the combined organic layer was dried, concentrated, and puri-
fied by flash column chromatography (CH2Cl2/MeOH, 93:7). Yield
49 mg, 72%; 1H NMR (400 MHz, CD3OD): d=7.41–7.29 (m, 4H),
7.32–7.23 (m, 1H), 4.59 (s, 2H), 4.44–4.36 (m, 1H), 4.31–4.24 (m,
1H), 3.96 (d, J=9.8 Hz, 1H), 3.89–3.80 (m, 1H), 3.81–3.74 (m, 1H),
3.72–3.64 (m, 2H), 3.64–3.56 (m, 2H), 1.38 (s, 3H), 1.34 (s, 3H);
13C NMR (100 MHz, CD3OD): d=139.3, 139.3, 129.4, 129.0, 129.0,
128.8, 128.8, 109.9, 109.8, 78.0, 77.9, 77.2, 76.9, 75.0, 74.5, 74.5,
72.4, 71.8, 71.2, 71.0, 70.4, 70.3, 68.7, 65.2, 64.0, 28.3, 28.3, 25.9,
5,6:7,8-Di-O-isopropylidene-d-glycero-l-galactooct-2-ulose (10,
Scheme 4): Yield 142 mg, 89%; [a]21D =À9.4 (c=1.85, CHCl3);
1H NMR (400 MHz, CDCl3): d=4.59 (d, J=19.5 Hz, 1H), 4.54–4.42
(m, 2H), 4.36 (td, J=6.9, 4.2 Hz, 1H), 4.16 (dd, J=7.1, 4.2 Hz, 1H),
4.06 (td, J=8.5, 7.1 Hz, 2H), 3.94 (dd, J=8.5, 7.1 Hz, 2H), 3.48 (d,
J=6.4 Hz, 1H), 3.21 (d, J=5.9 Hz, 1H), 3.08 (brs, 1H), 1.45 (s, 3H),
1.43 (s, 3H), 1.41 (s, 3H), 1.37 (s, 3H); 13C NMR (100 MHz, CDCl3):
d=211.2, 110.5, 110.2, 79.6, 76.1, 75.7, 74.9, 73.9, 66.8, 65.8, 27.2,
27.2, 26.1, 25.2; IR (film, CHCl3): 3410, 2987, 2935, 1727, 1641, 1456,
1382, 1372 cmÀ1; HRMS (ESI) exact mass calcd for C14H24O8Na m/z
343.1369 [M+Na]+, found m/z 343.1378 [M+Na]+.
25.8; IR (ATR, ZnSe): 3301, 2986, 2941, 2878, 1455, 1434, 1382 cmÀ1
;
HRMS (ESI) exact mass calcd for C17H26O7Na m/z 365.1576 [M+
Na]+, found m/z 365.1582 [M+Na]+.
5,6:7,8-Di-O-isopropylidene-d-glycero-d-galactooct-2-ulose (12,
Scheme 5): Yield 136 mg, 85%; [a]24D = +5.4 (c=1.01, CHCl3);
d-Glycero-d-mannoheptitol (9b, Scheme 3) and d-glycero-d-glu-
coheptitol (9b, Scheme 3): The reaction was performed under
ChemistryOpen 2015, 4, 717 – 721
720
ꢀ 2015 The Authors. Published by Wiley-VCH Verlag GmbH & Co. KGaA, Weinheim